Better assessments needed to learn if cannabis could benefit patients with cystic fibrosis

2y
2m read
Summary

Development of related, evidence-based and peer-reviewed educational materials should be among future CF care team initiatives, the researchers added. Other providers included nurses, pharmacists, dietitians and psychology care team members. Just 18 per cent of patients polled in Vermont, where medical marijuana has been legal since 2004, felt their physician was a good source of information about the drug. A survey showed students in Israel feel unprepared to determine whether or not to use cannabis for pain management compared to their counterparts in Thailand. The lack of preparedness brings to mind another recent study, this time involving medical students.

Article Preview

Cystic fibrosis (CF) healthcare providers need to have a better understanding about whether or not cannabis has a role to play in treating symptoms, suggests a new study out of the U.S.

Investigators reached that conclusion after receiving input from 282 survey participants across all U.S. regions, 28 per cent of them being providers and 26 per cent of them being social workers. Other providers included nurses, pharmacists, dietitians and psychology care team members.

Researchers wanted to determine respondent awareness of things like awareness of current cannabis laws in their respective states, prescribing practices for medical marijuana, screening...

Read the full article @ The Growth Op